Author
Emily Zhang
Recent research
- Health & MedicineOpen access
The US Food and Drug Administration (FDA) has historically exercised substantial regulatory flexibility to adjust the type, amount, and quality of evidence necessary to support drug approval for areas of unmet need. Our objective was to characterize how FDA officials described an...
- AI & ComputingOpen access
Heterogeneous Treatment Effects in Panel Data: Insights into the Healthy Incentives Program
Problem definition: We study how adding new vendors to the Massachusetts Healthy Incentives Program (HIP), a food subsidy program, affects program utilization. This is an instance of a core problem in causal inference: estimating heterogeneous treatment effects (HTEs) using panel...